Sign In
10 May 2023 17:05
MGC Pharmaceuticals Ltd.
PDMR Notification
10 May 2023
ASX, LSE: MXC
MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') wishes to advise that the following Persons Discharging Managerial Responsibilities (PDMR) have dealt with shares in MGC Pharma, and this notification is made in accordance the UK Market Abuse Regulations.
The shares subject of this notice were issued to the PDMR as part of their working contracts and as consideration for services rendered in lieu of cash payments. In addition to the issue, there was also a disposal of shares by one PDMR.
Following the issue of these shares, the Company has 3,349,692,950 ordinary shares in issue, each with one voting right. Therefore, the Company's total number of ordinary shares in issue and voting rights is 3,349,692,950 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
1 | Details of the person discharging managerial responsibilities/person closely associated
| ||||
(a) | Name | Amir Polak | |||
2 | Reason for the notification
| ||||
(a) | Position
| Chief Pharmaceutical Development Officer | |||
(b) | Initial notification/amendment
| Initial | |||
(c) | If amendment: reason
| n/a | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
Full name of entity | MGC Pharmaceuticals Limited
| ||||
Legal Entity Identifier Code | 213800HRE3FQJ6RK4H10
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| ||||
(a) | Description of the financial instrument, type of instrument | Fully Paid Ordinary Shares | |||
(b) | Identification Code (ISIN)
| AU000000MXC6 | |||
(c) | Nature of transaction | Disposal of shares
| |||
(d) | Currency | Price | Volume | Total | |
AUD | $0.008 | 500,000 | $4,000 | ||
Aggregated information | |||||
AUD | $0.008 | 500,000 | $4,000 | ||
(e) | Date of transaction | 1. 2023-05-04 | |||
(f) | Place of transaction | Australian Stock Exchange | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| ||||
(a) | Description of the financial instrument, type of instrument | Fully Paid Ordinary Shares | |||
(b) | Identification Code (ISIN)
| AU000000MXC6 | |||
(c) | Nature of transaction | Shares issued as consideration for services rendered | |||
(d) | Currency | Price | Volume | Total | |
AUD | $0.0107 | 7,209,112 | $77,137 | ||
Aggregated information | |||||
AUD | $0.0107 | 7,209,112 | $77,137 | ||
(e) | Date of transaction
| 2023-05-05 | |||
(f) | Place of transaction
| Outside a trading venue | |||
1 | Details of the person discharging managerial responsibilities/person closely associated
| ||||
(a) | Name | Itay Nissim | |||
2 | Reason for the notification
| ||||
(a) | Position
| Chief Manufacturing and Supply Chain Officer | |||
(b) | Initial notification/amendment
| Initial | |||
(c) | If amendment: reason
| n/a | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
Full name of entity | MGC Pharmaceuticals Limited
| ||||
Legal Entity Identifier Code | 213800HRE3FQJ6RK4H10
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| ||||
(a) | Description of the financial instrument, type of instrument | Fully Paid Ordinary Shares | |||
(b) | Identification Code (ISIN)
| AU000000MXC6 | |||
(c) | Nature of transaction | Shares issued as consideration for services rendered. | |||
(d) | Currency | Price | Volume | Total | |
AUD | $0.0107 | 6,946,963 | $74,333 | ||
Aggregated information | |||||
AUD | $0.0107 | 6,946,963 | $74,333 | ||
(e) | Date of transaction
| 2023-05-05 | |||
(f) | Place of transaction
| Outside a trading venue | |||
1 | Details of the person discharging managerial responsibilities/person closely associated
| ||||
(a) | Name | Robert Clements | |||
2 | Reason for the notification
| ||||
(a) | Position
| Chief Commercial Officer | |||
(b) | Initial notification/amendment
| Initial | |||
(c) | If amendment: reason
| n/a | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
Full name of entity | MGC Pharmaceuticals Limited
| ||||
Legal Entity Identifier Code | 213800HRE3FQJ6RK4H10
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| ||||
(a) | Description of the financial instrument, type of instrument | Fully Paid Ordinary Shares | |||
(b) | Identification Code (ISIN)
| AU000000MXC6 | |||
(c) | Nature of transaction | Shares issued as consideration for services rendered. | |||
(d) | Currency | Price | Volume | Total | |
AUD | $0.0107 | 7,537,673 | $80,653 | ||
Aggregated information | |||||
AUD | $0.0107 | 7,537,673 | $80,653 | ||
(e) | Date of transaction
| 2023-05-05 | |||
(f) | Place of transaction
| Outside a trading venue | |||
1 | Details of the person discharging managerial responsibilities/person closely associated
| ||||
(a) | Name | Tom Cairns | |||
2 | Reason for the notification
| ||||
(a) | Position
| Chief Accounting Officer | |||
(b) | Initial notification/amendment
| Initial | |||
(c) | If amendment: reason
| n/a | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
Full name of entity | MGC Pharmaceuticals Limited
| ||||
Legal Entity Identifier Code | 213800HRE3FQJ6RK4H10
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| ||||
(a) | Description of the financial instrument, type of instrument | Fully Paid Ordinary Shares | |||
(b) | Identification Code (ISIN)
| AU000000MXC6 | |||
(c) | Nature of transaction | Shares issued as consideration for services rendered. | |||
(d) | Currency | Price | Volume | Total | |
AUD | $0.0107 | 6,408,682 | $68,573 | ||
Aggregated information | |||||
AUD | $0.0107 | 6,408,682 | $68,573 | ||
(e) | Date of transaction
| 2023-05-05 | |||
(f) | Place of transaction
| Outside a trading venue | |||
1 | Details of the person discharging managerial responsibilities/person closely associated
| ||||
(a) | Name | Yifat Steuer | |||
2 | Reason for the notification
| ||||
(a) | Position
| Chief Operating Officer and Deputy CEO | |||
(b) | Initial notification/amendment
| Initial | |||
(c) | If amendment: reason
| n/a | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
Full name of entity | MGC Pharmaceuticals Limited
| ||||
Legal Entity Identifier Code | 213800HRE3FQJ6RK4H10
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| ||||
(a) | Description of the financial instrument, type of instrument | Fully Paid Ordinary Shares | |||
(b) | Identification Code (ISIN)
| AU000000MXC6 | |||
(c) | Nature of transaction | Shares issued as consideration for services rendered. | |||
(d) | Currency | Price | Volume | Total | |
AUD | $0.0107 | 11,359,813 | $121,550 | ||
Aggregated information | |||||
AUD | $0.0107 | 11,359,813 | $121,550 | ||
(e) | Date of transaction
| 2023-05-05 | |||
(f) | Place of transaction
| Outside a trading venue | |||
1 | Details of the person discharging managerial responsibilities/person closely associated
| ||||
(a) | Name | Yair Tal | |||
2 | Reason for the notification
| ||||
(a) | Position
| Chief Information Security Officer | |||
(b) | Initial notification/amendment
| Initial | |||
(c) | If amendment: reason
| n/a | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
Full name of entity | MGC Pharmaceuticals Limited
| ||||
Legal Entity Identifier Code | 213800HRE3FQJ6RK4H10
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| ||||
(a) | Description of the financial instrument, type of instrument | Fully Paid Ordinary Shares | |||
(b) | Identification Code (ISIN)
| AU000000MXC6 | |||
(c) | Nature of transaction | Shares issued as consideration for services rendered. | |||
(d) | Currency | Price | Volume | Total | |
AUD | $0.0107 | 7,078,038 | $75,732 | ||
Aggregated information | |||||
AUD | $0.0107 | 7,078,038 | $75,732 | ||
(e) | Date of transaction
| 2023-05-05 | |||
(f) | Place of transaction
| Outside a trading venue | |||
1 | Details of the person discharging managerial responsibilities/person closely associated
| ||||
(a) | Name | Nicole Godress | |||
2 | Reason for the notification
| ||||
(a) | Position
| Global Chief Sales Officer MGC Medical | |||
(b) | Initial notification/amendment
| Initial | |||
(c) | If amendment: reason
| n/a | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
Full name of entity | MGC Pharmaceuticals Limited
| ||||
Legal Entity Identifier Code | 213800HRE3FQJ6RK4H10
| ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| ||||
(a) | Description of the financial instrument, type of instrument | Fully Paid Ordinary Shares | |||
(b) | Identification Code (ISIN)
| AU000000MXC6 | |||
(c) | Nature of transaction | Shares issued as consideration for services rendered. | |||
(d) | Currency | Price | Volume | Total | |
AUD | $0.0107 | 876,636 | $9,380 | ||
Aggregated information | |||||
AUD | $0.0107 | 876,636 | $9,380 | ||
(e) | Date of transaction
| 2023-05-05 | |||
(f) | Place of transaction
| Outside a trading venue | |||
--Ends--
Authorised for release by the Managing Director, for further information please contact:
MGC Pharmaceuticals Ltd Roby Zomer CEO & Managing Director +61 8 6382 3390 info@mgcpharma.co.uk | MGC Pharmaceuticals Ltd Arron Canicais / Rowan Harland Joint Company Secretaries +61 8 6382 3390 info@mgcpharma.co.uk |
UK PR Advisors Tavistock Charles Vivian / Tim Pearson +44 207 920 3150 mgcpharma@tavistock.co.uk | UK Brokers Peterhouse Capital Charles Goodfellow / Lucy Williams +44 207 469 0930 cg@peterhousecap.com / lw@peterhousecap.com |
UK Financial and Corporate Advisor SW4 Partners Rupert Fane / Nilesh Patel rupert@sw4partners.com / nilesh@sw4partners.com |
Follow the stocks
